Skip to main content
Top
Published in: Endocrine 2/2021

01-11-2021 | Foreign Body Aspiration | Original Article

Cytology versus calcitonin assay in fine-needle aspiration biopsy wash-out fluid (FNAB-CT) in diagnosis of medullary thyroid microcarcinoma

Authors: Ziyuan Liu, Wenzhong Zhou, Rulai Han, Wei Zhou, Jie Zhang, Haorong Li, Zhihan Wan, Yan Jin, Liyun Shen, Yulin Zhou, Shu Wang, Xi Chen, Lei Ye

Published in: Endocrine | Issue 2/2021

Login to get access

Abstract

Purpose

Widespread use of sensitive ultrasound examination led to an increasing detection of medullary thyroid microcarcinoma (micro-MTC). This prospective study evaluated the diagnostic accuracy of Fine-needle Aspiration Biopsy Cytology (FNAB-C) and calcitonin assay in Fine-needle Aspiration Biopsy wash-out fluid (FNAB-CT) in thyroid nodules less than 1 cm with elevated serum calcitonin(sCT).

Methods

87 thyroid nodules from 60 patients with elevated sCT (>10 pg/ml) were included and 51 were thyroid nodules less than 1cm. FNAB-CT and FNAB-C were performed to distinguish medullary thyroid carcinoma (MTC) lesions before surgery, histopathologic diagnoses served as main reference standards.

Results

FNAB-CT had a greater performance over FNAB-C for preoperative diagnosis of MTC (diagnostic accuracy: 98.85 vs 61.90%, sensitivity: 98.55 vs 55.07%, specificity: 100 vs 97.44%), especially for micro-MTC: FNAB-C established a sensitivity and diagnostic accuracy of 48.78 and 58% respectively, while FNAB-CT reached 97.56% sensitivity and 98.04% diagnostic accuracy.

Conclusions

FNAB-CT demonstrated high diagnostic accuracy in diagnosing micro-MTC. Patients with microscopic thyroid nodules and elevated sCT level should perform FNAB-CT to exclude the diagnosis of MTC lesions.
Appendix
Available only for authorised users
Literature
1.
go back to reference L. Ceolin, M. Duval, A.F. Benini, C.V. Ferreira, A.L. Maia, Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives. Endocr. Relat. Cancer 26, R499–R518 (2019)CrossRef L. Ceolin, M. Duval, A.F. Benini, C.V. Ferreira, A.L. Maia, Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives. Endocr. Relat. Cancer 26, R499–R518 (2019)CrossRef
2.
go back to reference H.S. Kazaure, S.A. Roman, J.A. Sosa, Medullary thyroid microcarcinoma: a population-level analysis of 310 patients. Cancer 118, 620–7 (2012)CrossRef H.S. Kazaure, S.A. Roman, J.A. Sosa, Medullary thyroid microcarcinoma: a population-level analysis of 310 patients. Cancer 118, 620–7 (2012)CrossRef
3.
go back to reference H. Kwon, W.G. Kim, T.Y. Sung, M.J. Jeon, D.E. Song, Y.M. Lee et al. Changing trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinoma. J. Surg. Oncol. 113, 152–8 (2016)CrossRef H. Kwon, W.G. Kim, T.Y. Sung, M.J. Jeon, D.E. Song, Y.M. Lee et al. Changing trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinoma. J. Surg. Oncol. 113, 152–8 (2016)CrossRef
4.
go back to reference A. Machens, H. Dralle, Surgical cure rates of sporadic medullary thyroid cancer in the era of calcitonin screening. Eur. J. Endocrinol. 175, 219–28 (2016)CrossRef A. Machens, H. Dralle, Surgical cure rates of sporadic medullary thyroid cancer in the era of calcitonin screening. Eur. J. Endocrinol. 175, 219–28 (2016)CrossRef
5.
go back to reference R.W. Randle, C.J. Balentine, G.E. Leverson, J.A. Havlena, R.S. Sippel, D.F. Schneider et al. Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Surgery 161, 137–146 (2017)CrossRef R.W. Randle, C.J. Balentine, G.E. Leverson, J.A. Havlena, R.S. Sippel, D.F. Schneider et al. Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Surgery 161, 137–146 (2017)CrossRef
6.
go back to reference F. Torresan, C. Mian, E. Cavedon, M. Iacobone, Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening. Langenbecks Arch. Surg. 404, 411–419 (2019)CrossRef F. Torresan, C. Mian, E. Cavedon, M. Iacobone, Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening. Langenbecks Arch. Surg. 404, 411–419 (2019)CrossRef
7.
go back to reference N. Choi, W.J. Moon, J.H. Lee, J.H. Baek, D.W. Kim, S.W. Park, Ultrasonographic findings of medullary thyroid cancer: differences according to tumor size and correlation with fine needle aspiration results. Acta Radio. 52, 312–6 (2011)CrossRef N. Choi, W.J. Moon, J.H. Lee, J.H. Baek, D.W. Kim, S.W. Park, Ultrasonographic findings of medullary thyroid cancer: differences according to tumor size and correlation with fine needle aspiration results. Acta Radio. 52, 312–6 (2011)CrossRef
8.
go back to reference A. Machens, H. Dralle, Biological relevance of medullary thyroid microcarcinoma. J. Clin. Endocrinol. Metab. 97, 1547–53 (2012)CrossRef A. Machens, H. Dralle, Biological relevance of medullary thyroid microcarcinoma. J. Clin. Endocrinol. Metab. 97, 1547–53 (2012)CrossRef
9.
go back to reference G.C. Yang, K. Fried, P.H. Levine, Detection of medullary thyroid microcarcinoma using ultrasound-guided fine needle aspiration cytology. Cytopathology 24, 92–8 (2013)CrossRef G.C. Yang, K. Fried, P.H. Levine, Detection of medullary thyroid microcarcinoma using ultrasound-guided fine needle aspiration cytology. Cytopathology 24, 92–8 (2013)CrossRef
10.
go back to reference J.H. Kim, J.S. Pyo, W.J. Cho, Clinicopathological Significance and Prognosis of Medullary Thyroid Microcarcinoma: A Meta-analysis. World J. Surg. 41, 2551–2558 (2017)CrossRef J.H. Kim, J.S. Pyo, W.J. Cho, Clinicopathological Significance and Prognosis of Medullary Thyroid Microcarcinoma: A Meta-analysis. World J. Surg. 41, 2551–2558 (2017)CrossRef
11.
go back to reference R. Elisei, V. Bottici, F. Luchetti, G. Di Coscio, C. Romei, L. Grasso et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J. Clin. Endocrinol. Metab. 89, 163–8 (2004)CrossRef R. Elisei, V. Bottici, F. Luchetti, G. Di Coscio, C. Romei, L. Grasso et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J. Clin. Endocrinol. Metab. 89, 163–8 (2004)CrossRef
12.
go back to reference G. Costante, D. Meringolo, C. Durante, D. Bianchi, M. Nocera, S. Tumino et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J. Clin. Endocrinol. Metab. 92, 450–5 (2007)CrossRef G. Costante, D. Meringolo, C. Durante, D. Bianchi, M. Nocera, S. Tumino et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J. Clin. Endocrinol. Metab. 92, 450–5 (2007)CrossRef
13.
go back to reference G. Costante, D. Meringolo, Calcitonin as a biomarker of C cell disease: recent achievements and current challenges. Endocrine 67, 273–280 (2020)CrossRef G. Costante, D. Meringolo, Calcitonin as a biomarker of C cell disease: recent achievements and current challenges. Endocrine 67, 273–280 (2020)CrossRef
14.
go back to reference H. Vierhapper, B. Niederle, C. Bieglmayer, K. Kaserer, S. Baumgartner-Parzer, Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15, 1267–72 (2005)CrossRef H. Vierhapper, B. Niederle, C. Bieglmayer, K. Kaserer, S. Baumgartner-Parzer, Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15, 1267–72 (2005)CrossRef
15.
go back to reference S.A. Wells, S.L. Asa, H. Dralle, R. Elisei, D.B. Evans, R.F. Gagel et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25, 567–610 (2015)CrossRef S.A. Wells, S.L. Asa, H. Dralle, R. Elisei, D.B. Evans, R.F. Gagel et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25, 567–610 (2015)CrossRef
16.
go back to reference I.M. Boschin, F. Torresan, A. Toniato, M. Zane, E.C. Ide, G. Pennelli et al. Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications. Endocrine 45, 448–53 (2014)CrossRef I.M. Boschin, F. Torresan, A. Toniato, M. Zane, E.C. Ide, G. Pennelli et al. Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications. Endocrine 45, 448–53 (2014)CrossRef
17.
go back to reference H. Kwon, W.G. Kim, Y.M. Choi, E.K. Jang, M.J. Jeon, D.E. Song et al. A cut-off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma. Clin. Endocrinol. (Oxf.) 82, 598–603 (2015)CrossRef H. Kwon, W.G. Kim, Y.M. Choi, E.K. Jang, M.J. Jeon, D.E. Song et al. A cut-off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma. Clin. Endocrinol. (Oxf.) 82, 598–603 (2015)CrossRef
18.
go back to reference C. Colombo, U. Verga, C. Mian, S. Ferrero, M. Perrino, L. Vicentini et al. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J. Clin. Endocrinol. Metab. 97, 905–13 (2012)CrossRef C. Colombo, U. Verga, C. Mian, S. Ferrero, M. Perrino, L. Vicentini et al. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J. Clin. Endocrinol. Metab. 97, 905–13 (2012)CrossRef
19.
go back to reference M.B. Niederle, C. Scheuba, P. Riss, A. Selberherr, O. Koperek, B. Niederle, Early diagnosis of medullary thyroid cancer: are calcitonin stimulation tests still indicated in the era of highly sensitive calcitonin immunoassays? Thyroid 30, 974–984 (2020)CrossRef M.B. Niederle, C. Scheuba, P. Riss, A. Selberherr, O. Koperek, B. Niederle, Early diagnosis of medullary thyroid cancer: are calcitonin stimulation tests still indicated in the era of highly sensitive calcitonin immunoassays? Thyroid 30, 974–984 (2020)CrossRef
20.
go back to reference C. Nozières, L. Chardon, B. Goichot, F. Borson-Chazot, V. Hervieu, K. Chikh et al. Neuroendocrine tumors producing calcitonin: characteristics, prognosis and potential interest of calcitonin monitoring during follow-up. Eur. J. Endocrinol. 174, 335–41 (2016)CrossRef C. Nozières, L. Chardon, B. Goichot, F. Borson-Chazot, V. Hervieu, K. Chikh et al. Neuroendocrine tumors producing calcitonin: characteristics, prognosis and potential interest of calcitonin monitoring during follow-up. Eur. J. Endocrinol. 174, 335–41 (2016)CrossRef
21.
go back to reference P. Trimboli, G. Treglia, L. Guidobaldi, F. Romanelli, G. Nigri, S. Valabrega et al. Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis. Clin. Endocrinol. (Oxf.) 82, 280–5 (2015)CrossRef P. Trimboli, G. Treglia, L. Guidobaldi, F. Romanelli, G. Nigri, S. Valabrega et al. Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis. Clin. Endocrinol. (Oxf.) 82, 280–5 (2015)CrossRef
22.
go back to reference C.Y. Liu, A. Bychkov, S. Agarwal, Y. Zhu, J.F. Hang, C.R. Lai et al. Cytologic diagnosis of medullary thyroid carcinoma in the Asia-Pacific region. Diagn. Cytopathol. 49, 60–69 (2021)CrossRef C.Y. Liu, A. Bychkov, S. Agarwal, Y. Zhu, J.F. Hang, C.R. Lai et al. Cytologic diagnosis of medullary thyroid carcinoma in the Asia-Pacific region. Diagn. Cytopathol. 49, 60–69 (2021)CrossRef
23.
go back to reference M.P. Pusztaszeri, M. Bongiovanni, W.C. Faquin, Update on the cytologic and molecular features of medullary thyroid carcinoma. Adv. Anat. Pathol. 21, 26–35 (2014)CrossRef M.P. Pusztaszeri, M. Bongiovanni, W.C. Faquin, Update on the cytologic and molecular features of medullary thyroid carcinoma. Adv. Anat. Pathol. 21, 26–35 (2014)CrossRef
24.
go back to reference K.S. Dyhdalo, D.J. Chute, Barriers to the recognition of medullary thyroid carcinoma on FNA: Implications relevant to the new American Thyroid Association guidelines. Cancer Cytopathol. 126, 397–405 (2018)CrossRef K.S. Dyhdalo, D.J. Chute, Barriers to the recognition of medullary thyroid carcinoma on FNA: Implications relevant to the new American Thyroid Association guidelines. Cancer Cytopathol. 126, 397–405 (2018)CrossRef
25.
go back to reference H.J. Moon, E. Son, E.K. Kim, J.H. Yoon, J.Y. Kwak, The diagnostic values of ultrasound and ultrasound-guided fine needle aspiration in subcentimeter-sized thyroid nodules. Ann. Surg. Oncol. 19, 52–9 (2012)CrossRef H.J. Moon, E. Son, E.K. Kim, J.H. Yoon, J.Y. Kwak, The diagnostic values of ultrasound and ultrasound-guided fine needle aspiration in subcentimeter-sized thyroid nodules. Ann. Surg. Oncol. 19, 52–9 (2012)CrossRef
26.
go back to reference C. Colombo, U. Verga, C. Mian, S. Ferrero, M. Perrino, L. Vicentini et al. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J. Clin. Endocrinol. Metab. 97, 905–13 (2012)CrossRef C. Colombo, U. Verga, C. Mian, S. Ferrero, M. Perrino, L. Vicentini et al. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J. Clin. Endocrinol. Metab. 97, 905–13 (2012)CrossRef
27.
go back to reference F. Boi, I. Maurelli, G. Pinna, F. Atzeni, M. Piga, M.L. Lai et al. Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 92, 2115–8 (2007)CrossRef F. Boi, I. Maurelli, G. Pinna, F. Atzeni, M. Piga, M.L. Lai et al. Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 92, 2115–8 (2007)CrossRef
28.
go back to reference T. Kudo, A. Miyauchi, Y. Ito, Y. Takamura, N. Amino, M. Hirokawa, Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens. Thyroid 17, 635–8 (2007)CrossRef T. Kudo, A. Miyauchi, Y. Ito, Y. Takamura, N. Amino, M. Hirokawa, Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens. Thyroid 17, 635–8 (2007)CrossRef
29.
go back to reference P. Trimboli, F. Rossi, R. Baldelli, O. Laurenti, G. Nigri, C. Ventura et al. Measuring calcitonin in washout of the needle in patients undergoing fine needle aspiration with suspicious medullary thyroid cancer. Diagn. Cytopathol. 40, 394–8 (2012)CrossRef P. Trimboli, F. Rossi, R. Baldelli, O. Laurenti, G. Nigri, C. Ventura et al. Measuring calcitonin in washout of the needle in patients undergoing fine needle aspiration with suspicious medullary thyroid cancer. Diagn. Cytopathol. 40, 394–8 (2012)CrossRef
30.
go back to reference P. Trimboli, G. Nigri, F. Romanelli, D.D. Cicciarella Modica, A. Crescenzi, S. Valabrega et al. Medullary thyroid nodules by measurement of calcitonin (Ct) in aspiration needle washout in patients with multinodular goiter and moderately elevated serum Ct. Exp. Clin. Endocrinol. Diabetes 120, 234–7 (2012)CrossRef P. Trimboli, G. Nigri, F. Romanelli, D.D. Cicciarella Modica, A. Crescenzi, S. Valabrega et al. Medullary thyroid nodules by measurement of calcitonin (Ct) in aspiration needle washout in patients with multinodular goiter and moderately elevated serum Ct. Exp. Clin. Endocrinol. Diabetes 120, 234–7 (2012)CrossRef
31.
go back to reference C. Diazzi, B. Madeo, E. Taliani, L. Zirilli, S. Romano, A.R. Granata et al. The diagnostic value of calcitonin measurement in wash-out fluid from fine-needle aspiration of thyroid nodules in the diagnosis of medullary thyroid cancer. Endocr. Pr. 19, 769–79 (2013)CrossRef C. Diazzi, B. Madeo, E. Taliani, L. Zirilli, S. Romano, A.R. Granata et al. The diagnostic value of calcitonin measurement in wash-out fluid from fine-needle aspiration of thyroid nodules in the diagnosis of medullary thyroid cancer. Endocr. Pr. 19, 769–79 (2013)CrossRef
32.
go back to reference U. Mousa, A. Gursoy, H. Ozdemir, G. Moray, Medullary thyroid carcinoma in a patient with Hashimoto’s thyroiditis diagnosed by calcitonin washout from a thyroid nodule. Diagn. Cytopathol. 41, 644–6 (2013)CrossRef U. Mousa, A. Gursoy, H. Ozdemir, G. Moray, Medullary thyroid carcinoma in a patient with Hashimoto’s thyroiditis diagnosed by calcitonin washout from a thyroid nodule. Diagn. Cytopathol. 41, 644–6 (2013)CrossRef
33.
go back to reference P. Trimboli, N. Cremonini, L. Ceriani, E. Saggiorato, L. Guidobaldi, F. Romanelli et al. Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study. Clin. Endocrinol. (Oxf.) 80, 135–40 (2014)CrossRef P. Trimboli, N. Cremonini, L. Ceriani, E. Saggiorato, L. Guidobaldi, F. Romanelli et al. Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study. Clin. Endocrinol. (Oxf.) 80, 135–40 (2014)CrossRef
34.
go back to reference C. de Crea, M. Raffaelli, D. Maccora, C. Carrozza, G. Canu, G. Fadda et al. Calcitonin measurement in fine-needle aspirate washouts vs. cytologic examination for diagnosis of primary or metastatic medullary thyroid carcinoma. Acta Otorhinolaryngol. Ital. 34, 399–405 (2014)PubMed C. de Crea, M. Raffaelli, D. Maccora, C. Carrozza, G. Canu, G. Fadda et al. Calcitonin measurement in fine-needle aspirate washouts vs. cytologic examination for diagnosis of primary or metastatic medullary thyroid carcinoma. Acta Otorhinolaryngol. Ital. 34, 399–405 (2014)PubMed
35.
go back to reference A. Suzuki, M. Hirokawa, N. Takada, M. Higuchi, A. Ito, N. Yamao et al. Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan. Endocr. J. 64, 1099–1104 (2017)CrossRef A. Suzuki, M. Hirokawa, N. Takada, M. Higuchi, A. Ito, N. Yamao et al. Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan. Endocr. J. 64, 1099–1104 (2017)CrossRef
36.
go back to reference B. Marques, N. Cunha, R.G. Martins, A.R. Elvas, J. Couto, J. Santos et al. Lymph node metastases of medullary thyroid cancer: role of calcitonin in the washout fluid of fine-needle aspiration. Int J. Endocrinol. 2020, 9267972 (2020)CrossRef B. Marques, N. Cunha, R.G. Martins, A.R. Elvas, J. Couto, J. Santos et al. Lymph node metastases of medullary thyroid cancer: role of calcitonin in the washout fluid of fine-needle aspiration. Int J. Endocrinol. 2020, 9267972 (2020)CrossRef
37.
go back to reference P.M. Bossuyt, J.B. Reitsma, D.E. Bruns, C.A. Gatsonis, P.P. Glasziou, L. Irwig et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 351, h5527 (2015)CrossRef P.M. Bossuyt, J.B. Reitsma, D.E. Bruns, C.A. Gatsonis, P.P. Glasziou, L. Irwig et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 351, h5527 (2015)CrossRef
38.
go back to reference J.Y. Kwak, K.H. Han, J.H. Yoon, H.J. Moon, E.J. Son, S.H. Park et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology 260, 892–9 (2011)CrossRef J.Y. Kwak, K.H. Han, J.H. Yoon, H.J. Moon, E.J. Son, S.H. Park et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology 260, 892–9 (2011)CrossRef
39.
go back to reference E.S. Cibas, S.Z. Ali, The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid 27, 1341–1346 (2017)CrossRef E.S. Cibas, S.Z. Ali, The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid 27, 1341–1346 (2017)CrossRef
40.
go back to reference B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016)CrossRef B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016)CrossRef
Metadata
Title
Cytology versus calcitonin assay in fine-needle aspiration biopsy wash-out fluid (FNAB-CT) in diagnosis of medullary thyroid microcarcinoma
Authors
Ziyuan Liu
Wenzhong Zhou
Rulai Han
Wei Zhou
Jie Zhang
Haorong Li
Zhihan Wan
Yan Jin
Liyun Shen
Yulin Zhou
Shu Wang
Xi Chen
Lei Ye
Publication date
01-11-2021
Publisher
Springer US
Published in
Endocrine / Issue 2/2021
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-021-02759-1

Other articles of this Issue 2/2021

Endocrine 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine